Successful intravenous immunoglobulin treatment in severe COVID-19 pneumonia
Maurizia Lanza, Giorgio Emanuele Polistina, Pasquale Imitazione, Anna Annunziata, Valentina Di Spirito, Novella Carannante, Giuseppe Fiorentino
Abstract
We describe a 42-year old woman, admitted to our Department after 15 days of persistence of respiratory failure and treated with infusion of intravenous immunoglobulin with a successful outcome.
Topics & Concepts
MedicineCoronavirus disease 2019 (COVID-19)PneumoniaIntravenous Immunoglobulin TherapyAntibodySevere acute respiratory syndrome coronavirus 2 (SARS-CoV-2)Intensive care medicineRespiratory failure2019-20 coronavirus outbreakIntravenous ImmunoglobulinsImmunoglobulin GPersistence (discontinuity)ImmunologyInternal medicineVirologyInfectious disease (medical specialty)DiseaseOutbreakGeotechnical engineeringEngineeringCOVID-19 Clinical Research StudiesSARS-CoV-2 and COVID-19 ResearchPhagocytosis and Immune Regulation